AMANDA GRIMES to Follow-Up Studies
This is a "connection" page, showing publications AMANDA GRIMES has written about Follow-Up Studies.
Connection Strength
0.051
-
Real-World Use of Avatrombopag in Children and Adolescents With Immune Thrombocytopenia. Pediatr Blood Cancer. 2026 01; 73(1):e32143.
Score: 0.030
-
The cost of a "benign" condition: Healthcare utilization and infectious outcomes in young children with primary autoimmune neutropenia. Pediatr Blood Cancer. 2020 04; 67(4):e28146.
Score: 0.020